A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment

Agranulocytosis is a rare side effect of antithyroid drugs (ATD) that usually develops within the first 3‐6 months after starting treatment. We present a 64‐year‐old patient who developed agranulocytosis after starting ATD to treat relapsed Graves' disease. This patient had tolerated the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyunsam, Lee, Jeongmin, Ha, Jeonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132132/
https://www.ncbi.nlm.nih.gov/pubmed/30214745
http://dx.doi.org/10.1002/ccr3.1644
_version_ 1783354262597664768
author Kim, Hyunsam
Lee, Jeongmin
Ha, Jeonghoon
author_facet Kim, Hyunsam
Lee, Jeongmin
Ha, Jeonghoon
author_sort Kim, Hyunsam
collection PubMed
description Agranulocytosis is a rare side effect of antithyroid drugs (ATD) that usually develops within the first 3‐6 months after starting treatment. We present a 64‐year‐old patient who developed agranulocytosis after starting ATD to treat relapsed Graves' disease. This patient had tolerated the first course of ATD for 72 months. This was an unusual case in which a serious side effect developed during a second ATD course. It is essential that clinicians remain vigilant to the fact that antithyroid drugs can induce agranulocytosis several years after initiated.
format Online
Article
Text
id pubmed-6132132
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61321322018-09-13 A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment Kim, Hyunsam Lee, Jeongmin Ha, Jeonghoon Clin Case Rep Case Reports Agranulocytosis is a rare side effect of antithyroid drugs (ATD) that usually develops within the first 3‐6 months after starting treatment. We present a 64‐year‐old patient who developed agranulocytosis after starting ATD to treat relapsed Graves' disease. This patient had tolerated the first course of ATD for 72 months. This was an unusual case in which a serious side effect developed during a second ATD course. It is essential that clinicians remain vigilant to the fact that antithyroid drugs can induce agranulocytosis several years after initiated. John Wiley and Sons Inc. 2018-07-10 /pmc/articles/PMC6132132/ /pubmed/30214745 http://dx.doi.org/10.1002/ccr3.1644 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Kim, Hyunsam
Lee, Jeongmin
Ha, Jeonghoon
A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title_full A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title_fullStr A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title_full_unstemmed A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title_short A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
title_sort case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (atd) administration in a relapsed graves' disease patient who was tolerant to the first atd treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132132/
https://www.ncbi.nlm.nih.gov/pubmed/30214745
http://dx.doi.org/10.1002/ccr3.1644
work_keys_str_mv AT kimhyunsam acaseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment
AT leejeongmin acaseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment
AT hajeonghoon acaseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment
AT kimhyunsam caseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment
AT leejeongmin caseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment
AT hajeonghoon caseofantithyroiddruginducedagranulocytosisfromasecondantithyroiddrugsatdadministrationinarelapsedgravesdiseasepatientwhowastoleranttothefirstatdtreatment

Ejemplares similares